Mounjaro® Vancouver
The highest-efficacy weight loss medication currently available, Mounjaro® programs at Nova Skin & Wellness Centre, medically supervised with comprehensive lab testing and personalized care.
Mounjaro® at Nova; A New Standard in Medical Weight Loss
Mounjaro® represents a significant step forward in medical weight loss. While GLP-1 medications like Ozempic® have transformed weight loss medicine, Mounjaro® introduces a second mechanism that amplifies the metabolic effect producing greater average weight loss than any single-agonist therapy currently available.
At Nova Skin & Wellness Centre, Mounjaro® is prescribed and supervised by our licensed medically supervised as part of a comprehensive medical weight loss program. Every program begins with:
- Full laboratory testing
- A detailed metabolic assessment
- A personalized dosing plan designed for your individual response
Mounjaro® may be particularly well-suited for you if you have not achieved your goals with other GLP-1 medications, or if your health profile suggests you would benefit most from a dual-agonist approach. Your medically supervised will assess your suitability at your consultation.
What Is Mounjaro®?
Mounjaro contains Tirzepatide, a first-in-class injectable that activates two metabolic pathways simultaneously: GLP-1 and GIP receptors. Unlike other weight loss medications that target only GLP-1, this dual action produces a stronger, more comprehensive metabolic response, resulting in greater average weight loss than any single-pathway therapy currently available.
How the dual mechanism works:
GLP-1 receptor activation reduces appetite, slows gastric emptying, and improves insulin secretion. GIP receptor activation works differently, it enhances the GLP-1 effect, promotes fat metabolism in adipose tissue, reduces inflammation, and supports a more favourable body composition (preserving lean muscle mass while promoting fat loss). Together, these two pathways create a stronger, more comprehensive metabolic signal than either pathway alone.
Mounjaro® is administered as a once-weekly subcutaneous injection and is prescribed off-label for weight management in Canada, as permitted under Canadian medical law when clinically justified by a qualified medically supervised.
Real Results with Mounjaro®
Mounjaro® has demonstrated the highest average weight loss of any weight loss medication currently available. In a large-scale clinical trial, participants achieved an average body weight reduction of 15–22.5% depending on their dose, compared to just 3.1% in the placebo group.
To put that in context: a person starting at 200 lbs could expect to lose an average of 30–45 lbs over the course of their program. Beyond weight loss, participants also saw meaningful improvements in blood pressure, cholesterol, blood sugar, and energy levels.
Which Is Right for You?
Both Mounjaro® and Ozempic® are effective GLP-1-based weight loss medications, but they are not the same. The right choice depends on your health profile, treatment needs, and weight loss goals.
Mechanism
Ozempic® activates GLP-1 receptors only. Mounjaro® activates both GLP-1 and GIP receptors, producing a stronger metabolic signal and greater average weight loss.
Efficacy
Clinical studies show Mounjaro® can produce greater average weight loss than Ozempic® at comparable doses — approximately 15–22.5% compared with 12–15% with high-dose semaglutide.
Cost
Mounjaro® is generally more expensive than Ozempic® in BC. Pricing varies by dose and pharmacy. BC PharmaCare does not cover either medication for off-label weight loss use. Your Nova medically supervised will discuss all relevant costs transparently during your consultation.
Who It's Best For
Mounjaro® may be particularly appropriate for patients with significant weight loss goals, those who have not achieved adequate results with semaglutide, or those with insulin resistance, metabolic syndrome, or a profile that suggests stronger GIP involvement in their weight challenges. Your Nova medically supervised will assess which option is most appropriate for you.
Your Mounjaro® Program at Nova Skin and Wellness Centre
Comprehensive Assessment & Lab Testing
Your Mounjaro® program begins with a thorough medically supervised consultation and a full metabolic lab panel. Tirzepatide's dual mechanism makes a complete metabolic picture especially important. Your medical provider will assess blood sugar regulation, insulin sensitivity, thyroid function, kidney function, lipid profile, hormone levels, and inflammatory markers before making any prescription decision.
Personalized Dosing, Starting Low, Titrating Carefully
Mounjaro® is started at a low dose and gradually increased over time based on how your body responds. This careful approach allows your body to adjust comfortably while minimizing side effects. Your medical provider determines the pace—there is no fixed schedule.
Ongoing Medically Supervised Monitoring
Your progress is reviewed at regular intervals throughout your program. Dose adjustments are made based on your evolving response. Your medical provider remains available for questions, side effects, or changes in your health at every stage.
Nutritional Guidance & Lifestyle Support
At Nova, your program includes practical nutritional and lifestyle guidance designed to maximize your results and help you build habits that sustain your weight loss after your program ends.
Optional Add-Ons
For patients whose weight gain is connected to hormonal changes, such as perimenopause, menopause, or low testosterone, Nova offers hormone balancing alongside your Mounjaro® program. Additional add-ons include Lipo-B skinny shots and NAD+ therapy for enhanced metabolic support.
Who Is a Good Candidate for Mounjaro® at Nova?
Mounjaro® may be appropriate for patients who:
- Have a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition
- Have not achieved sufficient results with Ozempic
- Have significant insulin resistance, metabolic syndrome, or type 2 diabetes alongside weight concerns
- Have a large amount of weight to lose and are seeking the highest-efficacy option currently available
- Are not pregnant or breastfeeding
- Have no personal or family history of medullary thyroid carcinoma or MEN 2
What Our Vancouver Clients Say
Highly Recommended
Frequently Asked Questions; Mounjaro® Vancouver
Pricing varies by dose and pharmacy. BC PharmaCare does not cover Mounjaro® for weight loss. At Nova Skin & Wellness Centre, all medication costs are discussed transparently at your consultation.
Yes, Mounjaro® is available in BC and may be prescribed by a qualified medical provider for weight management as an off-label use, which is a legal and common clinical practice in Canada.
Results vary based on dose, individual metabolism, and lifestyle. In clinical trials, average weight loss over 72 weeks was 15–22.5% of body weight. Your Nova medical provider will set realistic expectations at your consultation.
On average, clinical data shows Mounjaro® produces greater weight loss than Ozempic®. However, the right choice depends on your health profile and goals. Your medical provider will recommend the most appropriate option at your consultation.
The most common side effects are gastrointestinal, nausea, vomiting, and constipation, most pronounced during dose escalation and typically diminishing as the body adjusts.
No referral is required. Book your consultation directly at Nova Skin & Wellness Centre.
Visit Us in Vancouver, BC
Nova Skin & Wellness Centre is located in South Granville, Vancouver, serving clients across Vancouver, West Vancouver, North Vancouver, Burnaby, and the Lower Mainland.